Free Trial

Adial Pharmaceuticals (ADIL) Short Interest Ratio & Short Volume

Adial Pharmaceuticals logo
$0.79 +0.02 (+2.21%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.77 -0.02 (-2.42%)
As of 02/21/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Adial Pharmaceuticals Short Interest Data

Adial Pharmaceuticals (ADIL) has a short interest of 60,600 shares, representing 0.95% of the float (the number of shares available for trading by the public). This marks a 195.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 129,342 shares to cover all short positions.

Current Short Interest
60,600 shares
Previous Short Interest
20,500 shares
Change Vs. Previous Month
+195.61%
Dollar Volume Sold Short
$50,298.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
6,410,000 shares
Float Size
6,360,000 shares
Short Percent of Float
0.95%
Today's Trading Volume
40,433 shares
Average Trading Volume
129,342 shares
Today's Volume Vs. Average
31%
Short Selling Adial Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Adial Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ADIL Short Interest Over Time

ADIL Days to Cover Over Time

ADIL Percentage of Float Shorted Over Time

Adial Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202560,600 shares $50,298.00 +195.6%1.0%0.3 $0.83
1/15/202520,500 shares $20,910.00 -9.3%0.3%0.1 $1.02
12/31/202422,600 shares $22,826.00 -60.8%0.4%0.1 $1.01
12/15/202457,600 shares $62,784.00 +16.4%0.9%0.3 $1.09
11/30/202449,500 shares $49,500.00 -71.7%0.8%0.3 $1.00
11/15/2024175,000 shares $185,500.00 +121.8%2.8%1.2 $1.06
10/31/202478,900 shares $78,900.00 +54.1%1.3%0.6 $1.00
10/15/202451,200 shares $48,757.76 -34.2%0.8%0.2 $0.95
9/30/202477,800 shares $77,722.20 -47.0%1.2%0 $1.00
9/15/2024146,700 shares $158,436.00 -46.2%2.3%0.1 $1.08
8/31/2024272,800 shares $267,616.80 -14.5%4.3%0.1 $0.98
8/15/2024318,900 shares $309,045.99 +8.3%5.1%0.1 $0.97
7/31/2024294,400 shares $306,176.00 +92.5%7.2%0.1 $1.04
7/15/2024152,900 shares $169,719.00 -6.4%3.7%0.1 $1.11
6/30/2024163,300 shares $187,795.00 -25.2%4.0%0.1 $1.15
6/15/2024218,200 shares $285,842.00 +33.5%5.3%0.1 $1.31
5/31/2024163,400 shares $236,930.00 +23.5%4.0%0.1 $1.45
5/15/2024132,300 shares $187,866.00 -20.8%3.2%0 $1.42
4/30/2024167,100 shares $284,070.00 -83.5%4.4%0 $1.70
4/15/20241,010,000 shares $2.64 million +11,509.2%26.7%0.2 $2.61
3/31/20248,700 shares $11,571.00 -91.8%0.2%0 $1.33
3/15/2024105,600 shares $166,848.00 +275.8%7.0%0 $1.58
2/29/202428,100 shares $57,324.00 -83.8%1.9%0 $2.04
2/15/2024173,300 shares $201,028.00 +691.3%11.5%0.6 $1.16
1/31/202421,900 shares $24,968.19 -41.1%1.5%0.2 $1.14
1/15/202437,200 shares $53,984.64 +11.4%2.6%0.4 $1.45
12/31/202333,400 shares $62,124.00 +29.5%3.2%0.3 $1.86
12/15/202325,800 shares $45,150.00 -37.4%2.4%0.3 $1.75
11/30/202341,200 shares $90,228.00 -22.3%3.9%0.6 $2.19
11/15/202353,000 shares $112,360.00 -1.5%5.0%1.2 $2.12
10/31/202353,800 shares $103,834.00 +93.5%5.1%0.8 $1.93
10/15/202327,800 shares $77,006.00 -45.3%2.6%0.4 $2.77
9/30/202350,800 shares $141,218.92 +49.4%4.8%0.3 $2.78
9/15/202334,000 shares $99,620.00 -47.4%3.3%0.3 $2.93
8/31/202364,600 shares $282,948.00 -12.6%6.2%0.5 $4.38
8/15/202373,900 shares $283,916.41 +121.3%7.1%0.6 $3.84
7/31/202333,400 shares $268,035.00 -97.7%N/A0.3 $8.03
7/15/20231,430,000 shares $395,538.00 +3,084.9%N/A0.6 $0.28
6/30/202344,900 shares $9,348.18 -24.3%N/A0 $0.21
6/15/202359,300 shares $14,528.50 -36.4%N/A0.3 $0.25
Here’s how you could profit from Elon’s NVIDIA partnership (Ad)

"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world.

5/31/202393,200 shares $24,511.60 -71.3%N/A0.3 $0.26
5/15/2023324,800 shares $104,812.96 -22.0%N/A0.5 $0.32
4/30/2023416,400 shares $143,449.80 +42.6%N/A0.6 $0.34
4/15/2023292,100 shares $87,045.80 -12.0%N/A0.4 $0.30
3/31/2023332,000 shares $116,200.00 -38.8%N/A0.5 $0.35
3/15/2023542,700 shares $201,884.40 +42.2%N/A0.8 $0.37
2/28/2023381,600 shares $167,904.00 +37.9%N/A0.6 $0.44
2/15/2023276,700 shares $102,655.70 +105.9%N/A1.1 $0.37
1/31/2023134,400 shares $63,168.00 -7.0%N/A0.6 $0.47
1/15/2023144,500 shares $46,254.45 +12.3%N/A1 $0.32
12/30/2022128,700 shares $27,670.50 -4.0%N/A1 $0.22
12/15/2022134,100 shares $32,572.89 +4.0%N/A1.4 $0.24
11/30/2022128,900 shares $34,789.98 -3.9%N/A1.3 $0.27
11/15/2022134,100 shares $39,438.81 -9.4%N/A0.9 $0.29
10/31/2022148,000 shares $43,660.00 -8.0%N/A0.9 $0.30
10/15/2022160,900 shares $52,614.30 -8.0%N/A0.6 $0.33
9/30/2022174,900 shares $61,215.00 -28.9%N/A0.3 $0.35
9/15/2022246,000 shares $119,777.40 -26.8%N/A0.3 $0.49
8/31/2022335,900 shares $180,311.12 +10.1%N/A0.4 $0.54
8/15/2022305,200 shares $181,594.00 -52.4%N/A0.4 $0.60
7/31/2022641,700 shares $417,105.00 -6.4%N/A0.9 $0.65
7/15/2022685,300 shares $1.12 million +17.9%N/A1.1 $1.63
6/30/2022581,500 shares $779,210.00 -27.4%N/A2.6 $1.34
6/15/2022801,200 shares $1.00 million -3.0%N/A4.7 $1.25
5/31/2022825,800 shares $1.04 million -4.8%N/A6.2 $1.26
5/15/2022867,100 shares $1.11 million +0.8%N/A7.6 $1.28
4/30/2022860,300 shares $1.21 million -8.3%N/A7.4 $1.41
4/15/2022938,000 shares $1.64 million +10.5%N/A7.8 $1.75
3/31/2022849,100 shares $1.71 million -2.1%N/A7.3 $2.01
3/15/2022867,000 shares $1.59 million +5.9%N/A7.4 $1.83
2/28/2022818,500 shares $1.69 million +8.3%N/A6.7 $2.06
2/15/2022755,600 shares $1.65 million +2.2%N/A5.1 $2.18
1/31/2022739,700 shares $1.54 million -9.0%4.3%4.3 $2.08
1/15/2022812,600 shares $2.13 million -5.7%4.7%4.1 $2.62
12/31/2021861,500 shares $2.33 million +1.1%5.0%3.8 $2.70
12/15/2021852,100 shares $2.29 million -9.5%4.9%3.1 $2.69
11/30/2021941,200 shares $2.62 million -5.5%5.6%3 $2.78
11/15/2021995,700 shares $3.15 million +13.7%5.9%2.6 $3.16
10/29/2021875,600 shares $2.81 million -11.0%5.3%1.9 $3.21
10/15/2021984,100 shares $3.82 million +3.4%6.0%2.1 $3.88
9/30/2021951,400 shares $4.08 million +10.3%5.8%1.6 $4.29
9/15/2021862,500 shares $3.54 million -3.0%5.3%1 $4.10
8/31/2021888,900 shares $3.64 million -10.0%5.6%0.7 $4.10
8/13/2021987,800 shares $3.24 million -9.4%6.0%0.8 $3.28
7/30/20211,090,000 shares $2.66 million +16.9%6.2%0.9 $2.44
7/15/2021932,600 shares $2.32 million -24.8%5.8%0.8 $2.49
6/30/20211,240,000 shares $3.16 million +103.0%7.9%1.2 $2.55
6/15/2021611,000 shares $1.65 million -13.4%3.9%0.8 $2.70
5/28/2021705,700 shares $1.74 million +11.4%4.6%2.9 $2.47
5/14/2021633,500 shares $1.30 million -4.2%N/A1.8 $2.05
Here’s how you could profit from Elon’s NVIDIA partnership (Ad)

"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world.

4/30/2021661,100 shares $1.44 million -9.7%N/A1.4 $2.17
4/15/2021731,900 shares $1.69 million +16.5%N/A1.2 $2.31
3/31/2021628,000 shares $1.44 million +14.8%N/A0.9 $2.30
3/15/2021547,200 shares $1.41 million +8.2%N/A0.8 $2.57
2/26/2021505,700 shares $1.39 million +7.6%N/A0.8 $2.75
2/12/2021469,800 shares $1.37 million +35.8%N/A0.7 $2.91
1/29/2021346,000 shares $743,900.00 -6.4%N/A0.6 $2.15
1/15/2021369,800 shares $761,788.00 +16.2%N/A0.7 $2.06
12/31/2020318,300 shares $569,757.00 -5.7%N/A0.5 $1.79
12/15/2020337,400 shares $651,182.00 -7.2%N/A0.1 $1.93
11/30/2020363,700 shares $709,215.00 -14.5%N/A0.1 $1.95
11/15/2020425,600 shares $783,104.00 -32.8%N/A0.2 $1.84
10/30/2020633,000 shares $1.13 million +13.2%N/A0.3 $1.79
10/15/2020559,200 shares $1.08 million -9.2%N/A0.2 $1.94
9/30/2020615,500 shares $1.37 million +9.7%N/A0.2 $2.23
9/15/2020561,000 shares $746,130.00 +9.0%N/A0.7 $1.33
8/31/2020514,800 shares $710,424.00 +97.6%N/A0.5 $1.38
8/14/2020260,500 shares $403,775.00 -16.6%N/A0.3 $1.55
7/31/2020312,200 shares $502,642.00 +283.5%N/A0.3 $1.61
7/15/202081,400 shares $108,262.00 +40.8%N/A0.2 $1.33
6/30/202057,800 shares $79,764.00 +72.0%0.6%0.1 $1.38
6/15/202033,600 shares $52,080.00 +309.8%0.4%0.1 $1.55
5/29/20208,200 shares $13,448.00 +110.3%0.1%0 $1.64
5/15/20203,900 shares $5,304.00 -13.3%0.1%0 $1.36
4/30/20204,500 shares $6,673.95 -45.8%0.1%0 $1.48
4/15/20208,300 shares $10,958.49 -34.1%0.1%0.1 $1.32
3/31/202012,600 shares $17,514.00 -69.2%0.2%0.2 $1.39
3/13/202040,900 shares $50,716.00 +42.0%0.6%0.6 $1.24
2/28/202028,800 shares $30,240.00 -24.0%0.4%0.3 $1.05

ADIL Short Interest - Frequently Asked Questions

What is Adial Pharmaceuticals' current short interest?

Short interest is the volume of Adial Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 60,600 shares of ADIL short. 0.95% of Adial Pharmaceuticals' shares are currently sold short. Learn More on Adial Pharmaceuticals' current short interest.

Which institutional investors are shorting Adial Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adial Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Adial Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.95% of Adial Pharmaceuticals' floating shares are currently sold short.

Is Adial Pharmaceuticals' short interest increasing or decreasing?

Adial Pharmaceuticals saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 60,600 shares, an increase of 195.6% from the previous total of 20,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Adial Pharmaceuticals' float size?

Adial Pharmaceuticals currently has issued a total of 6,410,000 shares. Some of Adial Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adial Pharmaceuticals currently has a public float of 6,360,000 shares.

How does Adial Pharmaceuticals' short interest compare to its competitors?

0.95% of Adial Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adial Pharmaceuticals: IN8bio, Inc. (0.75%), Aprea Therapeutics, Inc. (0.94%), Senti Biosciences, Inc. (3.44%), MIRA Pharmaceuticals, Inc. (5.28%), Lipocine Inc. (1.50%), BioAtla, Inc. (9.06%), MEI Pharma, Inc. (0.09%), Marker Therapeutics, Inc. (3.03%), Carisma Therapeutics, Inc. (3.27%), Sol-Gel Technologies Ltd. (0.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Adial Pharmaceuticals stock?

Short selling ADIL is an investing strategy that aims to generate trading profit from Adial Pharmaceuticals as its price is falling. ADIL shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Adial Pharmaceuticals?

A short squeeze for Adial Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADIL, which in turn drives the price of the stock up even further.

How often is Adial Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADIL, twice per month. The most recent reporting period available is January, 31 2025.




This page (NASDAQ:ADIL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners